FDA issues statement on CBD products
FDA commissioner Scott Gottlieb, issued the following statement on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products: “In recent years, we’ve seen a growing interest in the development of therapies and other FDA-